Want to see WINT full AI Analyst Report?
Windtree Therapeutics (WINT) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Istaroxime | Cardiogenic Shock | phase1AndPhase2 | Active Not Recruiting | A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C | Jul 26, 2023 | ― |
| Istaroxime | Cardiogenic Shock | Phase II | Completed | The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock | Mar 24, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Istaroxime | phase1AndPhase2 | Cardiogenic Shock | Active Not Recruiting | A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C | Jul 26, 2023 | ― |
| Istaroxime | Phase II | Cardiogenic Shock | Completed | The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock | Mar 24, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Windtree Therapeutics Inc (WINT) have in its pipeline
Windtree Therapeutics WINT is currently developing the following drugs: Istaroxime. These drug candidates are in various stages of clinical development as the company works toward FDA approval.